ArticleMolecular biology reports2026
Mechanistic assessment of hepato-reproductive toxicity of Mentha pulegium L. essential oil in rats.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMentha pulegium L. essential oil (MPEO), or pennyroyal oil, is widely used in traditional medicine, yet its safety remains debated because of pulegone, a constituent linked to hepatotoxicity and reproductive toxicity. This study evaluated MPEO's hepato-reproductive toxicity using an integrated in-silico and in vivo approach.
methodsPhytochemical composition was determined by GC-MS, while network pharmacology and molecular docking were used to identify likely targets and pathways. Reproductive and developmental toxicity were then assessed in Wistar rats (OECD Guideline 421) given 100, 200, or 400 mg/kg MPEO during premating, mating, gestation, and lactation, evaluating reproductive performance, developmental outcomes, biochemical markers, oxidative stress, hormone levels, and histopathology.
resultsGC-MS confirmed pulegone (42.72%) as the major constituent, and network pharmacology revealed 116 shared targets, with CYP19A1, ESR2, and HSD11B1 emerging as key hub genes in steroid hormone biosynthesis and estrogen signaling. Molecular docking showed favorable pulegone binding affinities for these targets (-5.9, -6.0, and - 6.6 kcal/mol, respectively). In vivo, MPEO exposure produced dose-dependent impairments in fertility, implantation, litter size, pup survival, and offspring growth, alongside elevated liver injury markers, oxidative stress, hormonal disruption, and histopathological damage in liver, testes, and ovaries.
conclusionPulegone-rich MPEO induces hepato-reproductive toxicity through endocrine disruption, oxidative tissue injury, and downregulation of steroid hormone biosynthesis signaling pathway. The novelty of this study lies in establishing the first multi-scale mechanistic link between computational targets (CYP19A1, ESR2, HSD11B1) and in vivo toxicity outcomes, offering insight for toxicology risk assessment and regulatory limits on pulegone-containing phytoactives.
Indexed as
Identifiers
42853327What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.